Aberrant Gene Expression Prostate Carcinoma

Running, not enrolling

Conditions studied: Prostate Cancer

In brief

The goal of the study is to gain a better understanding of the molecular changes responsible for causing prostate cancer and that examination of tissue and blood samples will help in the development of improved screening and therapeutic approaches.

Key facts

Study ID

NCT00868803

Run by

Lahey Clinic

People needed

5000

Starts

1995-04-01

Expected to finish

2030-04-01

Last updated by the study team

2026-07-13

Who can join

Age: any. Sex: male. Healthy volunteers: accepted.

You may qualify if…

• Diagnosed prostate cancer undergoing prostatectomy
• Suspicion of prostate cancer undergoing biopsy - negative biopsy
• Health volunteer (control group) - blood sample for PSA

You may not qualify if…

• Patients not fitting the inclusion criteria

Where it is running

• Lahey Clinic — Burlington, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.